A Prospective Observational Study on the Dynamic Changes of CTC Enumeration in Advanced NSCLC With 1st Line Chemotherapy
This is a prospective observational non-intervention study evaluating the dynamic CTC count
during the chemotherapy. Patients provide written informed consent and pass the screening.
Peripheral blood will be drawn before and after the first line chemotherapy. Analyze the
relationship between CTC count and clinical outcome. The time points of blood drawing are
set as following: once prior to 1st cycle of chemotherapy, once 1 week prior to 2nd cycle of
chemotherapy, posterior to 4th cycle (or less than 4th cycle) of chemotherapy and once when
progressive disease (PD). The specific blood tube CellSave Tube will be used, 7.5ml blood
sample every time. One follow-up (including by phone) be made every 3 month after PD until
death. The clinical outcome of first line chemotherapy will be ultimately obtained.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
dynamic CTC changes during chemotherapy
baseline, 3 weeks and up to progression disease of chemotherapy
No
Yi-Long Wu, MD
Principal Investigator
Guangdong General Hospital & Guangdong Academy of Medical Sciences
China: Ethics Committee
CTONG1202
NCT01740804
November 2012
December 2014
Name | Location |
---|